News in Focus- Constellium (NYSE:CSTM), Salix Pharmaceuticals (NASDAQ:SLXP), Tekmira Pharmaceuticals (NASDAQ:TKMR), Sigma-Aldrich (NASDAQ:SIAL) | The Cinema Post
Monday , November 12 2018
Home / Business News / News in Focus- Constellium (NYSE:CSTM), Salix Pharmaceuticals (NASDAQ:SLXP), Tekmira Pharmaceuticals (NASDAQ:TKMR), Sigma-Aldrich (NASDAQ:SIAL)

News in Focus- Constellium (NYSE:CSTM), Salix Pharmaceuticals (NASDAQ:SLXP), Tekmira Pharmaceuticals (NASDAQ:TKMR), Sigma-Aldrich (NASDAQ:SIAL)

Constellium NV (NYSE:CSTM) (Full FREE Analysis of CSTM And Be Sure To Notice The Intermediate Period) reported that that it has reached on a definitive contract to purchase Wise Metals Intermediate Holdings , a private aluminum sheet producer located in Muscle Shoals, Alabama. Whereas, shares of Constellium NV (NYSE:CSTM) traded down of -5.06% to finished at USD22.14 with market capitalization of 2.46 billion. Separately, a research note to investors, 2 analysts rates its stocks at “Hold,” 2 analysts rate it at “strong buy” and 7 rate it a “Buy.”

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) (Read Latest Free Analytic Facts on SLXP and Be Updated) as well as Cosmo Pharmaceuticals S.p.A. reported that they have decided to terminate their previously-announced merger agreement pursuant to which Salix would have combined with, and become a wholly-owned subsidiary of, Cosmo Technologies Limited, a subsidiary of Cosmo. Share price of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) climbed 1.18% to closed at $152.87 with the traded volume of 6.01 million shares as compared to the average volume of 1.84 million in last session. The 5 analysts rate its stocks at “Hold,” 6 analysts rate it at “strong buy” and 6 rate it a “Buy,” according to a recent a pool of analysts rating.

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (Read Experts View Here on TKMR Upcoming Performance) declared that it has achieved a development milestone supporting a $1.5M payment from Monsanto, following completion of specified program objectives. This work is part of the research program under the Option Agreement Tekmira signed with the agriculture company, which the Company announced on January 13, 2014. As, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has 1.24 beta factor with last traded share price of $29.53 with positive change of 15.94%. On analytic notes; diverse intension of analysts reflects as, 2 analysts rates its stocks at “strong buy” and 2 rate it a “Buy.”

Sigma-Aldrich Corporation (NASDAQ:SIAL) (What Market Forces Produce Volatility in SIAL Share? Find Free Report Here)   declared on Friday that it has decided to purchase Cell Marque Corp., a maker of antibody reagents, in a move to strengthen its antibody portfolio for immunohistochemistry or IHC customers. Financial terms of the deal were not disclosed. Sigma-Aldrich Corporation (NASDAQ:SIAL) stock surged of 0.47% to closed at $136.08 with the total traded volume of 1.06 million shares. The consensus average revenue estimates are $690.00M for latest quarter, at the same time as 11 experts predict $717.53M revenues for the next three months of 2014.

For latest Market Updates Subscribes Here

Facebook Comments